Orthobiologics

Study results indicate that Rotation Medical’s Bioinductive Implant may consistently heal rotator cuff tears, increase tendon thickness and prevent tear progression....

SeaSpine received FDA 510(k) clearance to market OsteoBallast™ Demineralized Bone Matrix in Resorbable Mesh....

Regentis Biomaterials commenced first surgeries in its Phase III pivotal clinical trial of GelrinC in the treatment of focal knee cartilage defects....

SeaSpine commenced limited launch of OsteoStrand™ Demineralized Bone Fibers, for use in spinal fusion....

Prosidyan announced FDA 510(k) clearance and commercial launch of FIBERGRAFT BG Matrix, a bone graft substitute for posterolateral spinal fusion....

AMNIOX Medical introduced RESPINA™ cryopreserved umbilical cord/amniotic membrane matrix, with application in microdiscectomy....

Anika Therapeutics completed enrollment in its second pivotal Phase III trial evaluating CINGAL® HA/corticosteroid viscosupplement for the treatment of knee...

Cerapedics’ i-FACTOR™ Peptide Enhanced Bone Graft is now in use at >150 U.S. hospitals....

LifeNet Health introduced PliaFX® Strip allograft, comprising 100% cortical bone fibers, to be available in 1H18....

Artoss introduced NanoBone® QD bone graft, comprising NanoBone SBX putty in an application designed for quick delivery....